Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UNC569, the first small-molecule MER inhibitor, inhibits Mer activation and downstream signaling through ERK1/2 and AKTwith. UNC569 shows efficacy against acute lymphoblastic leukemia in vitro and in vivo.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 7,500 |
5 mg | 約5 days | ¥ 11,000 |
10 mg | 約5 days | ¥ 15,500 |
25 mg | 約5 days | ¥ 31,000 |
1 mL * 10 mM (in DMSO) | 約5 days | ¥ 12,000 |
説明 | UNC569, the first small-molecule MER inhibitor, inhibits Mer activation and downstream signaling through ERK1/2 and AKTwith. UNC569 shows efficacy against acute lymphoblastic leukemia in vitro and in vivo. |
ターゲット&IC50 | OAT3:2 µM (Km), OAT1:0.85 µM (Km) |
別名 | Lesinurad, RDEA 594, RDEA-594, RDEA594 |
分子量 | 426.26 |
分子式 | C17H13BrN3NaO2S |
CAS No. | 1151516-14-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
H2O: Insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lesinurad sodium 1151516-14-1 Lesinurad RDEA 594 RDEA-594 RDEA594 Inhibitor inhibitor inhibit